SCHEMBL5340962

SCHEMBL5340962

CCCc1ccc(S(=O)(=O)Nc2ccc3ncccc3c2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.72
SMN1; SMN2 Q16637 2/20 0.72
LMNA P02545 1/20 0.72
NR1I2 O75469 1/20 0.54
ATM Q13315 2/20 0.53
MAPT P10636 1/20 0.53
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
KDM4E B2RXH2 1/20 0.50
ALPL P05186 1/20 0.50
KIT P10721 1/20 0.49
NAMPT P43490 2/20 0.48
FFAR4 Q5NUL3 2/20 0.48
FFAR1 O14842 1/20 0.46
PFKFB3 Q16875 1/20 0.46
BRAF P15056 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ADRB2 P07550 2/20 0.46
ADRB1 P08588 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5389593 0.85 NR1I2 (0.58) ALDH1A1SMN1; SMN2LMNANR1I2ATM
SCHEMBL6978649 0.84 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2LMNAMAPTRAB9A
SCHEMBL5344513 0.82 ATM (0.52) ALDH1A1SMN1; SMN2LMNANR1I2ATM
SCHEMBL9237538 0.82 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2LMNAMAPTRAB9A
SCHEMBL6985862 0.82 ALDH1A1 (0.78) ALDH1A1SMN1; SMN2LMNAATMMAPT
SCHEMBL5335572 0.82 MAPT (0.57) ALDH1A1SMN1; SMN2LMNANR1I2ATM
SCHEMBL6981076 0.81 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2LMNAMAPTKMT2A
SCHEMBL6982196 0.81 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2LMNAMAPTKMT2A
SCHEMBL6978003 0.81 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2LMNAMAPTRAB9A
SCHEMBL1040688 0.81 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2LMNANR1I2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 ALDH1A1 378/4885SMN1; SMN2 4243/4885LMNA 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.